NCT02817113 2021-04-30Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck CancerOrient Europharma Co., Ltd.Phase 1 Terminated4 enrolled
NCT03109158 2019-04-29NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNanoCarrier Co., Ltd.Phase 1/2 Completed1 enrolled